Basic Helix-Loop-Helix (bHLH) transcription factors are a conserved family of proteins regulating gene expression by binding to E-box motifs (CANNTG) in DNA . Numbered identifiers like "36" typically denote specific family members. While no direct references to "BHLH36" exist in the provided sources, bHLH proteins are classified into functional clusters based on DNA-binding preferences and phylogenetic relationships . For example:
Hypothetically, BHLH36 could belong to one of these clusters, with roles inferred from homologous proteins.
Antibodies targeting bHLH transcription factors are critical for studying their DNA-binding activity, post-translational modifications, and subcellular localization. Key findings from antibody-related studies include:
For bHLH proteins, antibodies often target conserved domains. For instance, studies on rice bHLH25 utilized custom antibodies to detect oxidation states of methionine residues critical for DNA binding . Similar approaches could theoretically apply to BHLH36.
| Domain | Key Residues | Function |
|---|---|---|
| Basic region | Glu-13 | E-box recognition |
| Helix 1 | Leu-23 | Dimer stabilization |
| Loop region | Lys-41 | Flexibility for DNA scanning |
The absence of explicit references to BHLH36 Antibody highlights the need for:
BHLH36 belongs to the basic helix-loop-helix family of transcription factors. Structurally, the bHLH domain consists of approximately 50-60 amino acid residues divided into a basic region and an HLH region. The conserved basic region is critical for DNA binding while the HLH region facilitates dimerization .
The bHLH domain in plants typically contains 65 amino acid residues with 21 conserved residues showing greater than 50% consensus across family members. Three residues—Arg-16, Leu-29, and Leu-65—demonstrate extremely high conservation (>90% consensus), indicating their crucial functional importance . Specifically, Glu-13, Arg-16, and Arg-17 in the basic region are essential for DNA binding, while Leu-29 and Leu-65 in the helix region play vital roles in dimerization activity .
For experimental investigations, researchers should note that seven amino acid residues (Ile-20, Leu-26, Gln-30, Met-54, Ile-59, Ile-62, and Leu-65) show higher conservation in plants than animals, suggesting plant-specific functional adaptations that may be relevant when selecting epitopes for antibody development .
BHLH36 antibodies can be utilized in multiple experimental contexts:
Chromatin Immunoprecipitation (ChIP): For identifying DNA binding sites and regulatory targets of BHLH36.
Immunoprecipitation (IP): To isolate BHLH36 protein complexes and identify interaction partners.
Western Blotting: For detecting BHLH36 protein expression levels in different tissues or under various conditions.
Immunohistochemistry/Immunofluorescence: To analyze tissue-specific localization patterns.
EMSA (Electrophoretic Mobility Shift Assay): To assess DNA binding activity and specificity.
When designing experiments, consider that bHLH transcription factors often function as part of larger regulatory complexes. For instance, in anthocyanin biosynthesis regulation, bHLH factors frequently interact with MYB transcription factors and WD40 repeat proteins .
BHLH36 antibodies are typically supplied in lyophilized form . For optimal stability and activity:
Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles that can compromise antibody integrity .
Transport: The product is shipped at 4°C and should be stored immediately at the recommended temperature upon receipt .
Reconstitution: When reconstituting lyophilized antibodies, use sterile techniques and appropriate buffers (typically PBS with 0.1% BSA).
Working solutions: Store aliquots of working dilutions at -20°C to avoid repeated freeze-thaw cycles.
| Condition | Recommendation |
|---|---|
| Long-term storage | Lyophilized form at -20°C |
| Shipping | 4°C |
| Thawing | Gentle thawing at 4°C |
| Freeze-thaw cycles | Minimize; aliquot before freezing |
Validating antibody specificity is critical, especially when working with plant bHLH transcription factors that show significant homology within subfamilies. A comprehensive validation approach includes:
Western blot with recombinant protein: Express and purify recombinant BHLH36 as a positive control alongside other closely related bHLH family members to confirm specificity.
Peptide competition assay: Pre-incubate the antibody with the immunizing peptide before application in Western blot or immunohistochemistry. Signal reduction confirms specificity.
Knockout/knockdown validation: Compare antibody reactivity in wild-type versus BHLH36 knockout/knockdown tissues. This is particularly important when working with highly conserved transcription factor families.
Mass spectrometry confirmation: Immunoprecipitate with the BHLH36 antibody and analyze by mass spectrometry to confirm the identity of the captured protein.
Cross-species reactivity testing: Given the conserved nature of the bHLH domain, test antibody reactivity across multiple plant species of interest. Antibodies raised against Arabidopsis BHLH36 may react with orthologous proteins in other species like grape or cassava, depending on epitope conservation .
BHLH36 DNA binding can be investigated using both in vitro and in vivo approaches:
In vitro methods:
EMSA (Electrophoretic Mobility Shift Assay): Detects direct interactions between purified BHLH36 and DNA fragments containing putative binding sites. Based on conserved residues analysis, BHLH36 likely binds to E-box motifs (CANNTG) .
DNA-Protein Pull-down: Using biotinylated DNA oligonucleotides containing predicted binding sites to capture BHLH36 from nuclear extracts.
Surface Plasmon Resonance (SPR): For quantitative measurement of binding kinetics and affinity.
In vivo methods:
ChIP-seq: To identify genome-wide binding sites under physiological conditions. This approach can reveal both expected E-box motifs and potentially novel binding sequences.
DAP-seq (DNA Affinity Purification sequencing): For high-throughput identification of binding sites using purified BHLH36 protein and fragmented genomic DNA.
When designing experiments, consider that bHLH proteins can be classified based on their DNA binding preferences :
G-box binding proteins (containing His/Lys-9, Glu-13 and Arg-17)
Non-G-box E-box binding proteins (containing Glu-13 and Arg-16)
Non-E-box binding proteins
Non-DNA-binding proteins (lacking basic region residues)
Based on conserved amino acid analysis, BHLH36 should be categorized accordingly to predict its binding preferences prior to experimental validation .
Based on research with related bHLH transcription factors, BHLH36 may be involved in anthocyanin biosynthesis regulation . To investigate this function:
Heterologous expression: Express BHLH36 in a heterologous system (such as Arabidopsis) and measure changes in anthocyanin accumulation. Successful examples include VvbHLH1 from grape increasing enzyme activity related to flavonoid synthesis .
Transient expression assays: Use transient expression in plant tissues (like grape berries) to observe short-term effects on anthocyanin pathway genes .
Co-expression with MYB factors: Since bHLH factors often function in complexes with MYB transcription factors to regulate anthocyanin synthesis, design co-expression experiments with relevant MYB partners .
Targeted gene expression analysis: Analyze the expression of key structural genes in the anthocyanin pathway (such as UFGT, DFR) in BHLH36 overexpression or knockdown lines .
Protein-protein interaction studies: Investigate interactions between BHLH36 and known regulators of anthocyanin synthesis using yeast two-hybrid, BiFC, or co-immunoprecipitation.
The comprehensive approach used for studying VdbHLH037 in grapes, which combined phylogenetic analysis, interaction network prediction, and functional validation through both transient expression and stable transformation, provides an excellent methodological framework .
Several technical challenges may arise when working with BHLH36 antibodies in plant tissues:
Cross-reactivity with related bHLH proteins: Due to the high conservation within the bHLH domain, antibodies may recognize multiple family members. This is particularly challenging since plants typically contain numerous bHLH transcription factors (115 in grape, for example) . Use epitopes from less conserved regions when possible.
Low abundance in native tissues: Transcription factors are often expressed at low levels, requiring sensitive detection methods. Consider using nuclear extraction protocols to enrich for transcription factors before immunoprecipitation or Western blotting.
Plant-specific interference compounds: Plant tissues contain various compounds (polyphenols, polysaccharides) that can interfere with antibody-based techniques. Include polyvinylpyrrolidone (PVP) or polyvinylpolypyrrolidone (PVPP) in extraction buffers to remove these compounds.
Post-translational modifications: BHLH36 activity may be regulated by phosphorylation, ubiquitination, or other modifications. These modifications can affect antibody recognition, so consider using multiple antibodies targeting different epitopes.
Tissue-specific expression: Expression may vary significantly across tissues and developmental stages. Conduct preliminary expression analyses to identify optimal tissues for study.
Chromatin immunoprecipitation for plant transcription factors requires specific optimizations:
Crosslinking optimization: Test different formaldehyde concentrations (typically 1-3%) and crosslinking times (5-20 minutes) to find the optimal balance between sufficient crosslinking and DNA shearing efficiency.
Tissue disruption: Since plant cell walls present a barrier, ensure thorough tissue disruption using mechanical methods (grinding in liquid nitrogen) before crosslinking, or optimize the order of crosslinking and disruption for your specific tissue.
Sonication conditions: Plant chromatin often requires more aggressive sonication than animal samples. Optimize sonication parameters (amplitude, cycle number, and duration) to achieve DNA fragments of 200-500 bp.
Antibody selection and validation: For ChIP applications, confirm that your BHLH36 antibody recognizes the native (potentially modified) form of the protein bound to DNA using a preliminary ChIP-PCR with primers for a known or predicted target gene.
Controls: Include proper controls such as input DNA, mock IP (no antibody), and IP with non-specific IgG. When possible, include a biological negative control using tissue where BHLH36 is not expressed or using BHLH36 knockout lines.
Several cutting-edge technologies offer new approaches to study BHLH36 function:
CRISPR-Cas9 genome editing: Generate precise mutations in BHLH36 or its target sequences to study function. Consider creating mutations in specific DNA-binding residues (Glu-13, Arg-16, Arg-17) to disrupt DNA binding while maintaining protein interactions .
Single-cell transcriptomics: Analyze BHLH36-regulated gene expression at single-cell resolution to better understand cell-type-specific functions.
Proximity labeling (BioID or APEX): Fuse BHLH36 to a biotin ligase to identify proximal proteins in living cells, providing insights into its native protein interaction network.
CUT&RUN or CUT&Tag: These methodologies offer higher signal-to-noise ratios than traditional ChIP for identifying transcription factor binding sites, requiring fewer cells and less antibody.
Live-cell imaging with tagged BHLH36: Using split fluorescent proteins or other tagging strategies to visualize BHLH36 dynamics and interactions in living cells.
Computational tools can significantly enhance BHLH36 antibody research:
Epitope prediction: Utilize computational tools to identify unique regions within BHLH36 for antibody development, avoiding highly conserved domains that might lead to cross-reactivity with other bHLH family members.
Homology modeling: Generate structural models of BHLH36 based on known bHLH structures to predict DNA binding interfaces and protein interaction surfaces.
Phylogenetic analysis: Comprehensive phylogenetic analysis can place BHLH36 within the appropriate subfamily context (such as III(f) subfamily for anthocyanin regulation or III(d+e) for stress responses) , informing functional predictions.
Protein-protein interaction networks: Construct predicted interaction networks to identify potential BHLH36 co-factors, similar to approaches used for anthocyanin-related bHLH factors .
Integrated multi-omics analysis: Combine transcriptomics, proteomics, and metabolomics data to build comprehensive models of BHLH36-regulated pathways.
Expanding BHLH36 research to non-model species requires specific considerations:
Ortholog identification: Use phylogenetic approaches to identify true BHLH36 orthologs rather than paralogs or other bHLH family members. The classification into 25 subfamilies provides a framework for identifying functionally equivalent proteins across species .
Antibody cross-reactivity testing: Test existing BHLH36 antibodies for cross-reactivity with the orthologous protein in your species of interest. Western blot with recombinant proteins can confirm recognition.
Gene expression systems: Develop appropriate heterologous or homologous expression systems. For example, transient expression in target tissues (as demonstrated with grape bHLH factors) can provide rapid functional insights .
Species-specific pathway considerations: Consider species-specific aspects of the pathways regulated by BHLH36. For instance, if studying anthocyanin biosynthesis, account for species-specific variations in the pathway components and regulation.
Reference gene selection: For qPCR studies, carefully validate reference genes in your specific species, as commonly used reference genes may show variable expression across different plant species and conditions.